Gabapentin )

PreclinicalSmall molecule

NNational Institute of Mental Health (NIMH)

Gabapentin ) is one of 4 small molecule programs targeting Abdominal Surgeries. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Abdominal SurgeriesActive, not recruiting

Abdominal SurgeriesPreclinical

Active, not recruiting

Competition

Competitive Landscape

3 competitors in Abdominal Surgeries

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 1

4 2

Marcaine

IInnocoll

Phase 1

2 3

Esmeron

FFresenius Kabi USA, LLC

Preclinical

1 4

Gabapentin )

NNational Institute of Mental Health (NIMH)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

N/AActive, not recruiting

Abdominal Surgeries

NCT07019103

Clinical

Trials by Indication[1]

Mood Disorder1 trial

New Drugs in the Treatment of Mood Disorders

Completed·NNational Institute of Mental Health (NIMH)·Phase 2·NCT00001482·60 enrolled

Abdominal Surgeries1 trial

Pain Management Protocol in Abdominal Surgeries in City of Erbil

Active, not recruiting·HHaroon Muhammad Khalil·N/A·NCT07019103·136 enrolled

Unspecified1 trial

A Phase 4, Randomized, Double-Blind, Placebo and Active-Controlled, Single-Dose, Four-Way Crossover Study Evaluating the Abuse Potential of Two Doses of Gabapentin Taken Orally in Healthy, Non-Drug-Dependent Participants With Sedative Drug Use Experience

Completed· Viatris logo

Viatris·Approved·NCT07777965·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Gabapentin ). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gabapentin ) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gabapentin ). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Institute of Mental Health (NIMH) company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Institute of Mental Health (NIMH)

Gabapentin )

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Mood Disorder1 trial

Abdominal Surgeries1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News